Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia.

Desmarais, Julie Eve; Beauclair, Linda; Annable, Lawrence; Bélanger, Marie-Claire; Kolivakis, Theodore T; Margolese, Howard C.

Afiliação

Desmarais JE; Clinical Psychopharmacology and Therapeutics Unit, Allan Memorial Institute, McGill University Health Centre, 1025 Pine Avenue West, Montreal, Quebec, Canada H3A 1A1.
Beauclair L; Clinical Psychopharmacology and Therapeutics Unit, Allan Memorial Institute, McGill University Health Centre, Montreal, Quebec, Canada Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Annable L; Clinical Psychopharmacology and Therapeutics Unit, Allan Memorial Institute, McGill University Health Centre, Montreal, Quebec, Canada Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Bélanger MC; Clinical Psychopharmacology and Therapeutics Unit, Allan Memorial Institute, McGill University Health Centre, Montreal, Quebec, Canada Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Kolivakis TT; Clinical Psychopharmacology and Therapeutics Unit, Allan Memorial Institute, McGill University Health Centre, Montreal, Quebec, Canada Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Margolese HC; Clinical Psychopharmacology and Therapeutics Unit, Allan Memorial Institute, McGill University Health Centre, Montreal, Quebec, Canada Department of Psychiatry, McGill University, Montreal, Quebec, Canada.

Ther Adv Psychopharmacol ; 4(6): 257-67, 2014 Dec.

Article em En | MEDLINE | ID: mdl-25489477